CAR-T toxicity management and steroid use in high-grade BCell lymphoma: impact on real-world survival outcomes in the UK
dc.contributor.author | Sanderson, R. | |
dc.contributor.author | Kuhnl, A. | |
dc.contributor.author | Tholouli, E. | |
dc.contributor.author | Menne, T. F. | |
dc.contributor.author | Patel, Amit | |
dc.contributor.author | Chaganti, S. | |
dc.contributor.author | Besley, C. | |
dc.contributor.author | Nicholson, E. | |
dc.contributor.author | Latif, A. L. | |
dc.contributor.author | Jones, C. | |
dc.contributor.author | Rubio, L. | |
dc.contributor.author | Stenson, C. | |
dc.contributor.author | Mathew, A. | |
dc.contributor.author | Sharplin, K. | |
dc.contributor.author | Bazin, J. | |
dc.contributor.author | Neill, L. | |
dc.contributor.author | Cheok, K. P. L. | |
dc.contributor.author | Jalowiec, K. A. A. | |
dc.contributor.author | Roddie, C. | |
dc.contributor.author | O'Reilly, M. A. | |
dc.date.accessioned | 2022-10-19T13:13:17Z | |
dc.date.available | 2022-10-19T13:13:17Z | |
dc.date.issued | 2021 | en |
dc.identifier.citation | Sanderson R, Kuhnl A, Tholouli E, Menne TF, Patel A, Chaganti S, et al. CAR-T Toxicity Management and Steroid Use in High-Grade BCell Lymphoma: Impact on Real-World Survival Outcomes in the UK. Blood. 2021 Nov;138. PubMed PMID: WOS:000736398802073. | en |
dc.identifier.doi | 10.1182/blood-2021-149501 | en |
dc.identifier.uri | http://hdl.handle.net/10541/625632 | |
dc.language.iso | en | en |
dc.relation.url | https://dx.doi.org/10.1182/blood-2021-149501 | en |
dc.title | CAR-T toxicity management and steroid use in high-grade BCell lymphoma: impact on real-world survival outcomes in the UK | en |
dc.type | Meetings and Proceedings | en |
dc.contributor.department | King's College Hospital, London, United Kingdom | en |
dc.identifier.journal | Blood | en |
dc.description.note | en] |